| 21.03.2025 07:00 | HVO | Notice of Results | RNS |
| 07.03.2025 07:00 | HVO | Director/PDMR Shareholding | RNS |
| 27.02.2025 07:00 | HVO | Acquisition of Cryostore for up to £3.2m | RNS |
| 17.02.2025 17:54 | HVO | IN BRIEF: hVIVO signs GBP2 million deal as aims to progress hMPV care | Alliance |
| 17.02.2025 07:00 | HVO | £2m hMPV characterisation study contract | RNS |
| 05.02.2025 07:00 | HVO | Shionogi reports positive RSV trial results | Reach |
| 03.02.2025 16:37 | HVO | hVIVO wins contract for RSV drug human trial for Inhalon Biopharma | Alliance |
| 03.02.2025 07:00 | HVO | RSV contract signed with Inhalon Biopharma | RNS |
| 31.01.2025 13:24 | HVO | Holding(s) in Company | RNS |
| 31.01.2025 07:00 | HVO | Holding(s) in Company | RNS |
| 29.01.2025 11:42 | HVO | hVIVO eyes double-digit revenue rise, announces new acquisition | Alliance |
| 29.01.2025 07:01 | HVO | Acquisition: two Clinical Research Units from CRS | RNS |
| 29.01.2025 07:00 | HVO | Trading update | RNS |
| 27.01.2025 11:18 | HVO | hVIVO stock rises in response to vaccine testing contract | Alliance |
| 27.01.2025 10:04 | OBI, HVO, GOOD | AIM WINNERS & LOSERS: hVIVO wins deal; Good Energy backs buyout | Alliance |
| 27.01.2025 07:00 | HVO | LOI signed for Phase 3 Whooping Cough trial | RNS |
| 21.01.2025 12:16 | HVO | hVIVO subsidiary hLAB wins largest contract to date with US client | Alliance |
| 21.01.2025 07:00 | HVO | £3.2m hLAB project | RNS |
| 14.01.2025 07:00 | HVO | Holding(s) in Company | RNS |
| 13.01.2025 07:00 | HVO | hMPV challenge model update | Reach |
| 06.11.2024 07:00 | HVO | Holding(s) in Company | RNS |
| 05.11.2024 07:00 | HVO | Presentation at Jefferies London Healthcare Conf | Reach |
| 11.10.2024 07:00 | HVO | Long Term Incentive Plan/ PDMR Notification | RNS |
| 07.10.2024 07:00 | HVO | Positive results from RSV human challenge trial | Reach |
| 30.09.2024 07:00 | HVO | Launch of full suite of hLAB standalone services | Reach |
| 24.09.2024 07:00 | HVO | Holding(s) in Company | RNS |
| 17.09.2024 07:00 | HVO | Holding(s) in Company | RNS |
| 10.09.2024 15:53 | HVO | hVIVO hails "record" half-year revenue, as profit soars 70% higher | Alliance |
| 10.09.2024 07:00 | HVO | Interim results | RNS |
| 05.09.2024 07:00 | HVO | Holding(s) in Company | RNS |
| 03.09.2024 11:31 | TRX, ATR, SQZ | UK earnings, trading statements calendar - next 7 days | Alliance |
| 20.08.2024 07:00 | HVO | Notice of results | RNS |
| 06.08.2024 15:07 | HVO | Holding(s) in Company | RNS |
| 05.08.2024 07:00 | HVO | Euronext cancellation | RNS |
| 24.07.2024 13:55 | HVO | Holding(s) in Company | RNS |
| 23.07.2024 14:48 | HVO | Director/PDMR Shareholding | RNS |
| 17.07.2024 14:33 | HVO | hVIVO reports 31% revenue jump; relocation to improve efficiencies | Alliance |
| 17.07.2024 07:01 | HVO | Holding(s) in Company | RNS |
| 17.07.2024 07:00 | HVO | Trading update | RNS |
| 10.07.2024 13:41 | RNO, HVO, BRK | UK earnings, trading statements calendar - next 7 days | Alliance |
| 08.07.2024 07:00 | HVO | Holding(s) in Company | RNS |
| 03.07.2024 14:48 | HVO | Holding(s) in Company | RNS |
| 02.07.2024 20:03 | TXP, ECR, HELD | TRADING UPDATES: Creo extends contract; Belluscura raises funds | Alliance |
| 02.07.2024 07:02 | HVO | Change of registered address | RNS |
| 02.07.2024 07:01 | HVO | Capital Markets Day & Notice of trading update | RNS |
| 02.07.2024 07:00 | HVO | Influenza 2b field study contract | RNS |
| 03.06.2024 12:20 | HVO | hVIVO says Omicron contract validates move to Canary Wharf facility | Alliance |
| 03.06.2024 07:00 | HVO | £2.5m contract for Omicron characterisation study | RNS |
| 13.05.2024 16:16 | MYI, JUP, BIPS | UK dividends calendar - next 7 days | Alliance |
| 13.05.2024 13:02 | HVO | Result of AGM | RNS |
| 15.04.2024 07:00 | HVO | Annual Report & Notice of AGM | RNS |
| 11.04.2024 15:09 | WEIR, VSVS, VANQ | UK dividends calendar - next 7 days | Alliance |
| 09.04.2024 12:03 | HVO | hVIVO swings to profit and commences annual dividends as outlook rosy | Alliance |
| 09.04.2024 07:09 | HVO | Final results | RNS |
| 08.04.2024 09:53 | HVO, EGT | European Green Transition starts trading on London's AIM market | Alliance |
| 02.04.2024 13:21 | ULTP, SUS, JTC | UK earnings, trading statements calendar - next 7 days | Alliance |
| 27.03.2024 07:00 | HVO | Notice of Results | RNS |
| 22.03.2024 15:03 | HVO | Holding(s) in Company | RNS |
| 18.03.2024 11:23 | HVO | Investment firm European Green Transition plans listing on AIM | Alliance |
| 14.03.2024 07:00 | HVO | Holding(s) in Company | RNS |
| 15.02.2024 07:00 | HVO | Long Term Incentive Plan / PDMR Notification | RNS |
| 14.02.2024 19:55 | HVO | IN BRIEF: hVIVO Chair and non-exec director sell 30.0 million shares | Alliance |
| 14.02.2024 13:14 | HVO | Result of Secondary Placing | RNS |
| 14.02.2024 10:46 | HVO | IN BRIEF: hVIVO directors to sell total of 14 million shares | Alliance |
| 14.02.2024 07:00 | HVO | Proposed Secondary Placing of Ordinary Shares | RNS |
| 30.01.2024 11:39 | HVO | hVIVO shares up after "record year" across all metrics | Alliance |
| 30.01.2024 07:00 | HVO | Trading update | RNS |
| 08.01.2024 07:00 | HVO | Broker change | RNS |
| 02.01.2024 10:16 | HVO | hVIVO inks GBP6.3 million deal to test common cold treatment | Alliance |
| 02.01.2024 07:00 | HVO | £6.3m HRV contract signed with biotech client | RNS |
| 13.12.2023 11:44 | HVO | hVIVO signs deal to test RSV antiviral drug candidate with study model | Alliance |
| 13.12.2023 07:00 | HVO | £16.8m RSV contract & Trading ahead of guidance | RNS |
| 05.10.2023 11:45 | HVO | hVIVO celebrates positive results for Pneumagen's Neumifil in trial | Alliance |
| 05.10.2023 07:00 | HVO | Positive results from flu human challenge study | Reach |
| 12.09.2023 11:33 | HVO | hVIVO interim profit jumps on revenue increase; ups full-year guidance | Alliance |
